Guidelines for Malaria-Lymphatic Filariasis Co-Implementation in ...
Winnable Battle Lymphatic Filariasis presentation
-
Upload
publichealthfoundation -
Category
Health & Medicine
-
view
1.496 -
download
1
description
Transcript of Winnable Battle Lymphatic Filariasis presentation
![Page 1: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/1.jpg)
Eliminating Lymphatic Filariasis in the Americas
A Winnable Battle
Center for Global Health
Division of Parasitic Diseases and Malaria
![Page 2: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/2.jpg)
Lymphatic Filariasis (LF)
Caused by worms spread from person-to-person by the bite of infected mosquitoes
The worms live in the human lymphatic system and can cause: lymphedema (swelling) and elephantiasis in limbs and
breasts hydrocele (severe fluid accumulation) affecting men’s
genitalia
Microfilaria of Wuchereria bancrofti (CDC photo, DPDx)
Microfilaria of Brugia malayi (CDC photo, DPDx)
![Page 3: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/3.jpg)
Health and societal impacts of LF
CDC photos
lymphedema
elephantiasis
Usually develop years after initial infection Cause pain, severe and irreversible
disfigurement, loss of productivity, and social stigmatization
![Page 4: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/4.jpg)
LF: A costly and disabling NTD
One of the most disabling and economically costly neglected tropical diseases (NTDs) NTDs are a group of poverty-associated parasitic and
bacterial infections affecting more than 1 billion persons NTDs are responsible for tremendous suffering and
economic loss More than 120 million persons are infected
with LF, a disease that can be eliminated
Photo courtesy Carter Center/Emily Staub
![Page 5: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/5.jpg)
Worldwide distribution of LF
1.34 billion at risk in world
![Page 6: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/6.jpg)
Global impact of LF
A leading cause of disability globally Endemic in 81 countries 44 million persons suffer from chronic
manifestations
Photos courtesy of CDC. Left: Dr. Susan Montgomery, Middle and Right: CDC PHIL
![Page 7: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/7.jpg)
Global Programme to Eliminate LF (GPELF)
Target elimination date of 2020 Launched by World Health Organization
(WHO) in 2000 Two-pronged strategy to:
1. Interrupt the spread of infection 2. Reduce the suffering of persons already infected
To interrupt infection, medication is distributed to entire at-risk population through mass drug administration (MDA) At least 5 rounds on MDA are needed to interrupt
transmission Treatment kills worms circulating in the blood
![Page 8: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/8.jpg)
GPELF: Progress and successes
53 countries have ongoing MDA campaigns 37 countries have administered 5 or more rounds of
MDA in many target areas 2.8 billion doses of medicine delivered in first 9 years
Treatment cost typically less than US $0.50 per person and often less than $0.10
Transmission interruption has protected 6.6 million newborns from becoming infected with the disease
Economic benefit of first 7 years of program estimated at $24 billion
Full economic benefit could exceed US $55 billion
![Page 9: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/9.jpg)
The economic impact of GPELF, 2000-2007
Table courtesy of WHO GPELF
![Page 10: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/10.jpg)
Passive Surveillance ( > 5 years)
“Mapping”TAS TAS TAS
n
Monitoring & Evaluation
1
Rounds annual mass drug administration (MDA)
2 3 4 5
Coverage
Impact Assessment
WHO Guidelines for LF Elimination Programs
Post-MDA Period
TAS = transmission assessment survey
![Page 11: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/11.jpg)
LF elimination in the Americas
The Americas is the first region targeted for elimination of LF Improvements in standard of living have reduced
disease prevalence in continental Americas and Caribbean Islands
In areas where disease remained (Costa Rica, Suriname, and Trinidad and Tobago), transmission was interrupted through selective and community treatment
Transmission still occurs in Guyana, Haiti, and parts of Brazil and the Dominican Republic
![Page 12: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/12.jpg)
Notable achievements in the Americas
Surveys carried out in the Dominican Republic suggest transmission interruption
MDA treatment scaling up in Guyana and Haiti 4.5 million of 8.6 million at-risk Haitians received MDA 3 million Haitians treated since January 2010 earthquake
Disease management programs operating in all four endemic countries
CDC photo
![Page 13: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/13.jpg)
Notable achievements in the Americas
Although there is still active transmission in Guyana, Haiti, and parts of Brazil and the Dominican Republic, each country has achieved notable success in the fight against LF
As of late 2009, nearly 5 million persons living in Americas had received MDA
Elimination in the Americas is within reach
![Page 14: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/14.jpg)
Progress in MDA for LF, WHO’s Region of the Americas, 2000-2009
Graph courtesy of WHO GPELF
![Page 15: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/15.jpg)
CDC and partner support
CDC and its partners: Work with each country’s ministry of health to
offer advice and expert consultation Develop monitoring and evaluation strategies Provide technical support Carry out operational research including
working to understand:• Adherence to medication• Optimal surveillance methods• Strategies to accelerate elimination
![Page 16: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/16.jpg)
Winning the battle against LF:What more can be done to eliminate LF by
2020?
Continue and scale-up MDA programs to interrupt transmission
Use operational research to develop strategies to accelerate the elimination of LF
Increase each country’s efforts to provide appropriate care for persons with filarial disease
Expand the reach of LF programs to include service delivery for other NTDs and health priorities
![Page 17: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/17.jpg)
CDC partners We would like to acknowledge and thank
our partners working to eliminate lymphatic filariasis: The Bill & Melinda Gates Foundation CBM International Eisai GlaxoSmithKline IMA World Health Inter-American Development Bank Merck Pan American Health Organization RTI International The Task Force for Global Health University of Notre Dame United States Agency for International Development (USAID)
![Page 18: Winnable Battle Lymphatic Filariasis presentation](https://reader034.fdocuments.us/reader034/viewer/2022051313/54b428494a795902568b4576/html5/thumbnails/18.jpg)
For more information please contact Centers for Disease Control and Prevention1600 Clifton Road NE, Atlanta, GA 30333Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348E-mail: [email protected] Web: www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Thank you
www.cdc.gov/winnablebattles
Center for Global HealthDivision of Parasitic Diseases and Malaria